You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (58)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Schizophrenia
 •Alert me on articles by topic

Evidence for Impaired Cortical Inhibition in Schizophrenia Using Transcranial Magnetic Stimulation

Zafiris J. Daskalakis, MD, FRCP(C); Bruce K. Christensen, PhD, CPsych; Robert Chen, MBB Chir, MSc, FRCP(C); Paul B. Fitzgerald, MBBS, MPM, FRANZCP; Robert B. Zipursky, MD, FRCP(C); Shitij Kapur, MD, PhD, FRCP(C)

Arch Gen Psychiatry. 2002;59:347-354.

Background  Cortical inhibition (CI) deficits have been proposed as a pathophysiologic mechanism in schizophrenia. This study employed 3 transcranial magnetic stimulation (TMS) paradigms to assess CI in patients with schizophrenia. Paired-pulse TMS involves stimulating with a lower-intensity pulse a few milliseconds before a higher-intensity pulse, thereby inhibiting the size of the motor evoked potential produced by the higher-intensity pulse. In the cortical silent period paradigm, inhibition is reflected by the silent period duration (ie, the duration of electromyographic activity cessation following a TMS-induced motor evoked potential). Transcallosal inhibition involves stimulation of the contralateral motor cortex several milliseconds prior to stimulation of the ipsilateral motor cortex, inhibiting the size of the motor evoked potential produced by ipsilateral stimulation.

Methods  We measured CI using these 3 paradigms in 15 unmedicated patients with schizophrenia (14 medication-naive and 1 medication-free for longer than 1 year) (13 were in the transcallosal inhibition paradigm), 15 medicated patients with schizophrenia (11 taking olanzapine, 1 risperidone, 1 quetiapine, 1 methotrimeprazine + perphenazine, 1 quetiapine + loxapine), and 15 healthy controls.

Results  Unmedicated patients demonstrated significant CI deficits compared with healthy controls across all inhibitory paradigms whereas medicated patients did not (at all inhibitory intervals, paired-pulse TMS: controls = 59.9%, medicated = 44.3%, unmedicated = 28.7%; cortical silent period: controls = 55.0 milliseconds, medicated = 60.4 milliseconds, unmedicated = 39.7 milliseconds; transcallosal inhibition: controls = 33.6%, medicated = 23.7%, unmedicated = 10.4%; P<.05).

Conclusions  These results suggest that schizophrenia is associated with deficits in CI and that antipsychotic medications may increase CI.


From the Schizophrenia and Continuing Care Program, Centre for Addiction and Mental Health, Department of Psychiatry (Drs Daskalakis, Christensen, Zipursky, and Kapur), and Division of Neurology, Toronto Western Hospital (Dr Chen), University of Toronto, Toronto, Ontario; and Dandenong Psychiatry Research Centre, Monash University and Dandenong Area Mental Health Service, Victoria, Australia (Dr Fitzgerald).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence for Impaired Long-Term Potentiation in Schizophrenia and Its Relationship to Motor Skill Leaning
Frantseva et al.
Cereb Cortex 2008;18:990-996.
ABSTRACT | FULL TEXT  

Dysfunctional Neural Plasticity in Patients With Schizophrenia
Daskalakis et al.
Arch Gen Psychiatry 2008;65:378-385.
ABSTRACT | FULL TEXT  

Increased cortical inhibition in persons with schizophrenia treated with clozapine
Daskalakis et al.
J Psychopharmacol 2008;22:203-209.
ABSTRACT  

Alternating and Postictal Psychoses: Review and a Unifying Hypothesis
Sachdev
Schizophr Bull 2007;33:1029-1037.
ABSTRACT | FULL TEXT  

The effects of inhibitory and facilitatory intracortical circuits on interhemispheric inhibition in the human motor cortex
Lee et al.
J. Physiol. 2007;580:1021-1032.
ABSTRACT | FULL TEXT  

Dopamine transporter genotype influences the physiological response to medication in ADHD
Gilbert et al.
Brain 2006;129:2038-2046.
ABSTRACT | FULL TEXT  

High Level Bilateral Talks. Focus on "Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Interhemispheric Inhibition"
Harris-Love and Cohen
J. Neurophysiol. 2005;94:1664-1665.
FULL TEXT  

Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Interhemispheric Inhibition
Pal et al.
J. Neurophysiol. 2005;94:1668-1675.
ABSTRACT | FULL TEXT  

Reduced Cerebellar Inhibition in Schizophrenia: A Preliminary Study
Daskalakis et al.
Am. J. Psychiatry 2005;162:1203-1205.
ABSTRACT | FULL TEXT  

Interactions between long latency afferent inhibition and interhemispheric inhibitions in the human motor cortex
Kukaswadia et al.
J. Physiol. 2005;563:915-924.
ABSTRACT | FULL TEXT  

Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand
Schwenkreis et al.
Neurology 2003;61:515-519.
ABSTRACT | FULL TEXT  

Organization of Ipsilateral Excitatory and Inhibitory Pathways in the Human Motor Cortex
Chen et al.
J. Neurophysiol. 2003;89:1256-1264.
ABSTRACT | FULL TEXT  

Transcranial Magnetic Stimulation: A New Investigational and Treatment Tool in Psychiatry
Daskalakis et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:406-415.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.